BREAKING
Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap 11 minutes ago LENZ Therapeutics, Inc. (LENZ) Reports Wider Q4 Loss Than Expected 15 minutes ago UTStarcom Holdings Corp. (UTSI) Reports Q2 Earnings 19 minutes ago LightInTheBox Holding Co., Ltd. (LITB) Q4 2025 Earnings Recap 29 minutes ago LightInTheBox Holding Co., Ltd. (LITB) Reports Q4 Earnings 32 minutes ago COMPASS Pathways plc (CMPS) Reports Q4 Earnings 43 minutes ago Core & Main, Inc. (CNM) Misses Q4 EPS Estimates by 32.3% 47 minutes ago Concentrix Corporation (CNXC) Misses Q1 EPS Estimates 53 minutes ago Sanara MedTech Inc. (SMTI) Misses Q4 EPS Estimates by 215.9% 59 minutes ago Achieve Life Sciences, Inc. (ACHV) Reports Wider Q4 Loss Than Expected 1 hour ago Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap 11 minutes ago LENZ Therapeutics, Inc. (LENZ) Reports Wider Q4 Loss Than Expected 15 minutes ago UTStarcom Holdings Corp. (UTSI) Reports Q2 Earnings 19 minutes ago LightInTheBox Holding Co., Ltd. (LITB) Q4 2025 Earnings Recap 29 minutes ago LightInTheBox Holding Co., Ltd. (LITB) Reports Q4 Earnings 32 minutes ago COMPASS Pathways plc (CMPS) Reports Q4 Earnings 43 minutes ago Core & Main, Inc. (CNM) Misses Q4 EPS Estimates by 32.3% 47 minutes ago Concentrix Corporation (CNXC) Misses Q1 EPS Estimates 53 minutes ago Sanara MedTech Inc. (SMTI) Misses Q4 EPS Estimates by 215.9% 59 minutes ago Achieve Life Sciences, Inc. (ACHV) Reports Wider Q4 Loss Than Expected 1 hour ago
ADVERTISEMENT
Analysis

Conagra Brands (CAG): A look at why shares took a dive today

Shares of Conagra Brands Inc. (NYSE: CAG) were down 5.5% in afternoon hours on Tuesday despite the company reporting better-than-expected revenue and earnings results for the fourth quarter of 2021. The branded foods provider cut its forecast for fiscal year 2022 as it felt the effects of inflation which led to the stock taking a […]

July 13, 2021 2 min read

Shares of Conagra Brands Inc. (NYSE: CAG) were down 5.5% in afternoon hours on Tuesday despite the company reporting better-than-expected revenue and earnings results for the fourth quarter of 2021. The branded foods provider cut its forecast for fiscal year 2022 as it felt the effects of inflation which led to the stock taking a […]

Shares of Conagra Brands Inc. (NYSE: CAG) were down 5.5% in afternoon hours on Tuesday despite the company reporting better-than-expected revenue and earnings results for the fourth quarter of 2021. The branded foods provider cut its forecast for fiscal year 2022 as it felt the effects of inflation which led to the stock taking a tumble.

Sales decline

In the fourth quarter of 2021, Conagra’s net sales dropped 16.7% year-over-year to $2.7 billion, hurt by a 10% drop in organic sales. Organic sales was impacted by volume decreases as the benefits from the pandemic-related spike in at-home food consumption got pared down. Sales results were also impacted by the divestitures of the H.K. Anderson, Peter Pan and Egg Beaters businesses.

Inflation

Inflation took a toll on Conagra’s margins and profitability during the fourth quarter. Gross profit decreased 22% due to a decline in net sales, inflation in cost of goods sold as well as lost profit from the divestitures. Gross margin decreased 172 basis points to 26.3% in Q4 on a reported basis.

The decrease in gross profit caused a 29% decline in adjusted net income to $261 million, or $0.54 per share. On a reported basis, net income increased nearly 54% to $310 million, or $0.64 per share, as gross profit declines were offset by tax benefits from the restructuring of the Ardent Mills joint venture investment.

Lowered outlook

Conagra believes the demand for its retail products will remain high during FY2022 due to shifts in customer preferences brought on by the pandemic. However, the company expects input cost inflation to be higher than expected during the upcoming year. The branded foods provider expects to tackle this cost increase through various actions including broad-based pricing.

Conagra anticipates a lag between the time it is hit with higher costs and when it realizes the benefit of its actions and the impact of this lag is expected to be at its highest during the first half of 2022. The company expects organic net sales growth in FY2022 to be approx. flat compared to FY2021.

Conagra lowered its guidance for adjusted EPS to $2.50 from the previous range of $2.63-2.73. Adjusted EPS in the second half of the fiscal year is estimated to be in line with the previous assumptions for FY2022.

Click here to read more on consumer stocks

ADVERTISEMENT